Why equal treatment is not always equitable: The impact of existing ethnic health inequalities in cost-effectiveness modeling

Population Health Metrics

Volumn 12, Issue 1, 2014, Pages

  McLeod, Melissa ^a   Blakely, Tony ^a   Kvizhinadze, Giorgi ^a   Harris, Ricci ^a  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

Cost effectiveness; Equity; Ethnicity; Heterogeneity; M ori; New Zealand

Indexed keywords

CANCER; COST-BENEFIT ANALYSIS; DISEASE INCIDENCE; DISEASE TREATMENT; EQUITY; HEALTH SERVICES; INDIGENOUS POPULATION; LIFE EXPECTANCY; MARKOV CHAIN; MORBIDITY; MORTALITY; PRIORITIZATION; SUBPOPULATION; SURVIVAL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COLON CANCER; COST EFFECTIVENESS ANALYSIS; ETHNICITY; FEMALE; HEALTH CARE COST; HEALTH CARE DISPARITY; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL;

NEW ZEALAND;

EID: 84902079673     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-12-15     Document Type: Article

References (28)

1. Dolan P, Shaw R, Tsuchiya A, Williams A. QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005, 14:197-208. 10.1002/hec.924, 15386656.
2. Franks P, Lubetkin EI, Melnikow J. Do personal and societal preferences differ by socio-demographic group?. Health Econ 2007, 16:319-325. 10.1002/hec.1152, 16929479.
3. Nord E, Richardson J, Street A, Kuhse H, Singer P. Maximizing health benefits vs egalitarianism: an Australian survey of health issues. Soc Sci Med 1995, 41:1429-1437. 10.1016/0277-9536(95)00121-M, 8560311.
4. Bleichrodt H, Diecidue E, Quiggin J. Equity weights in the allocation of health care: the rank-dependent QALY model. J Health Econ 2004, 23:157-171. 10.1016/j.jhealeco.2003.08.002, 15154692.
5. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999, 8:25-39. 10.1002/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-H, 10082141.
6. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997, 6:117-132. 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B, 9158965.
7. Johri M, Norheim OF. Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int J Technol Assess Health Care 2012, 28:125-132. 10.1017/S0266462312000050, 22494637.
8. New Zealand Medical Association Health equity position statement. N Z Med J 2011, 124:10-86. New Zealand Medical Association.
9. CSDH Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health. Final Report of the Commission on Social Determinants of Health 2008, 2008. Geneva: World Health Organization, CSDH.
10. National Institute for Health and Clinical Excellence Guide to the Methods of Technology Appraisal 2008, London: The Institute, National Institute for Health and Clinical Excellence.
11. Blakely T, Shaw C, Atkinson J, Cunningham R, Sarfati D. Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004. Cancer Causes Control 2011, 22:1307-1318. 10.1007/s10552-011-9804-x, 21717195.
12. Soeberg M, Blakely T, Sarfati D, Tobias M, Costilla R, Carter K, Atkinson J. CancerTrends: Trends in Cancer Survival by Ethnic and Socioeconomic Group, New Zealand 1991-2004 2012, Wellington: University of Otago and Ministry of Health.
13. Tobias M, Blakely T, Matheson D, Rasanathan K, Atkinson J. Changing trends in indigenous inequalities in mortality: lessons from New Zealand. Int J Epidemiol 2009, 38:1711-1722. 10.1093/ije/dyp156, 19332501.
14. Blakely T, Shaw C, Atkinson J, Tobias M, Bastiampillai N, Sloane K, Sarfati D, Cunningham R. CancerTrends: Trends in Cancer Incidence by Ethnic and Socioeconomic Group, New Zealand 1981-2004 2010, Wellington: University of Otago and Ministry of Health.
15. Blakely T, Tobias M, Atkinson J, Yeh L-C, Huang K. Tracking Disparity: Trends in Ethnic and Socioeconomic Inequalities in Mortality, 1981-2004 2007, Wellington: Ministry of Health.
16. Blakely T, Foster R, Wilson N., BODE3 team Burden of Disease Epidemiology, Equity and Cost-Effectiveness (BODE3) Study Protocol 2012, Wellington: University of Otago, BODE3 team.
17. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, Farje MR, Moncada G, Dutta A, Sazawal S, Dyer A, Seiler J, Aboyans V, Baker L, Baxter A, Benjamin EJ, Bhalla K, Bin Abdulhak A, Blyth F, Bourne R, Braithwaite T, Brooks P, Brugha TS, Bryan-Hancock C, Buchbinder R, Burney P, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143. 10.1016/S0140-6736(12)61680-8, 23245605.
18. Costilla R, Atkinson J, Blakely T. Incorporating Ethnic and Deprivation Variation to Cancer Incidence Estimates over 2006-2026 for ABC-CBA 2011, Wellington: University of Otago, Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, Technical Report No.5.
19. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol 2010, 39:589-610.
20. Dickman P, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004, 23:51-64. 10.1002/sim.1597, 14695639.
21. Blakely T, Costilla R, Soeberg M. Cancer Excess Mortality Rates Over 2006-2026 for ABC-CBA 2012, Wellington: University of Otago, Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, Technical Report No. 10.
22. Ministry of Health Health Loss in New Zealand: A report from the New Zealand Burden of Diseases, Injuries and Risk Factors Study, 2006-2016 2013, Wellington: Ministry of Health, Ministry of Health.
23. Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD. Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One 2013, 8(3):e58975. 10.1371/journal.pone.0058975, 3606430, 23533595.
24. Theuer CP, Taylor TH, Brewster WR, Anton-Culver H. Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 2006, 98:51-57. 2594807, 16532978.
25. Banham D, Lynch J, Karnon J. An equity-effectiveness framework linking health programs and healthy life expectancy. Aust J Prim Health 2011, 17:309-319. doi: 10.1071/PY11034, 10.1071/PY11034, 22112699.
26. Paulden M, Culyer AJ. Does Cost-effectiveness Analysis Discriminate Against Patients with Short Life Expectancy? Matters of Logic and Matters of Context 2010, York: University of York, CHE Research Paper 55.
27. Harris J. It's not NICE to discriminate. J Med Ethics 2005, 31:373-375. 10.1136/jme.2005.012906, 1734179, 15994352.
28. Holtgrave DR. HIV prevention, cost-utility analysis, and race/ethnicity: Methodological considerations and recommendations. Med Decis Mak 2004, 24:181-191.